REGULATORY INTELLIGENCE·Recall
Motto International Corp's Class I Recall: Undeclared Tadalafil in Unapproved Drug Exposes Critical Supply Chain Risks
Motto International Corp's Class I recall of Bull Platinum 30000 Capsules highlights critical regulatory non-compliance. The FDA found the product, distributed in Texas, contained undeclared tadalafil and was marketed without required NDA/ANDA approval. This event underscores the imperative for robust vendor qualification and rigorous analytical testing within pharmaceutical supply chains, particularly for products lacking transparent regulatory pathways, to mitigate significant health and business risks.
90-Day Activity